000			02190 a2200613 4500
005			20250516085930.0
264		0	_c20120604
008			201206s 0 0 eng d
022			_a1538-3652
024	7		_a10.1001/archdermatol.2011.2768 _2doi
040			_aNLM _beng _cNLM
100	1		_aGarcia-Doval, Ignacio
245	0	0	_aRisk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials. _h[electronic resource]
260			_bArchives of dermatology _cApr 2012
300			_a463-70 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAnti-Inflammatory Agents _xadverse effects
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aBiological Products _xadverse effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aKeratolytic Agents _xadverse effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPUVA Therapy _xadverse effects
650	0	4	_aPatient Selection
650	0	4	_aProportional Hazards Models
650	0	4	_aPsoriasis _xclassification
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRisk Assessment
650	0	4	_aSpain
700	1		_aCarretero, Gregorio
700	1		_aVanaclocha, Francisco
700	1		_aFerrandiz, Carlos
700	1		_aDaudén, Esteban
700	1		_aSánchez-Carazo, Jose-Luis
700	1		_aAlsina, Mercé
700	1		_aHerrera-Ceballos, Enrique
700	1		_aGómez-García, Francisco-José
700	1		_aFerrán, Marta
700	1		_aLópez-Estebaranz, Jose-Luis
700	1		_aHernanz, Jose-Manuel
700	1		_aBelinchón-Romero, Isabel
700	1		_aVilar-Alejo, Jaime
700	1		_aRivera, Raquel
700	1		_aCarrascosa, Jose-Manuel
700	1		_aCarazo, Cristina
773	0		_tArchives of dermatology _gvol. 148 _gno. 4 _gp. 463-70
856	4	0	_uhttps://doi.org/10.1001/archdermatol.2011.2768 _zAvailable from publisher's website
999			_c21708541 _d21708541